1. Home
  2. RCUS vs CSTM Comparison

RCUS vs CSTM Comparison

Compare RCUS & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$20.03

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$23.33

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
CSTM
Founded
2015
2010
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
RCUS
CSTM
Price
$20.03
$23.33
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
$28.89
$23.50
AVG Volume (30 Days)
1.2M
1.5M
Earning Date
02-24-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
$240,000,000.00
$7,969,000,000.00
Revenue This Year
N/A
$9.76
Revenue Next Year
N/A
$8.10
P/E Ratio
N/A
$29.61
Revenue Growth
N/A
11.22
52 Week Low
$6.50
$7.33
52 Week High
$26.40
$25.15

Technical Indicators

Market Signals
Indicator
RCUS
CSTM
Relative Strength Index (RSI) 38.96 60.45
Support Level $20.79 $21.95
Resistance Level $22.29 $25.15
Average True Range (ATR) 1.13 0.95
MACD -0.20 -0.03
Stochastic Oscillator 0.45 47.18

Price Performance

Historical Comparison
RCUS
CSTM

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

Share on Social Networks: